OneSkin

OneSkin is a longevity biotech company on a mission to transform how we think about skin and aging. Founded by four female PhDs, OneSkin develops science-backed topical products centered on its proprietary OS-01 peptide — the first ingredient scientifically proven to reduce skin's biological age by clearing senescent cells, improving the skin barrier, supporting DNA damage repair, and preventing accumulation of aged cells. The company combines rigorous in-house R&D, peer-reviewed publications, and ongoing clinical studies to validate claims, targeting the root cellular causes of skin aging rather than masking symptoms.